IBIO
IBIO
NASDAQ · Biotechnology

Ibio Inc

$2.17
+0.09 (+4.33%)
As of Mar 25, 4:46 PM ET ·
Financial Highlights (FY 2026)
Revenue
1.36M
Net Income
-62,509,764
Gross Margin
38.4%
Profit Margin
-4,594.3%
Rev Growth
-40.3%
D/E Ratio
0.91
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 38.4% 38.4% 65.3% 65.3%
Operating Margin -4,650.5% -4,185.5% -16.4% -13.7%
Profit Margin -4,594.3% -4,364.5% -16.3% -13.6%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 1.36M 2.28M 19.24M 18.65M
Gross Profit 522.5K 875.2K 12.56M 12.17M
Operating Income -63,275,400 -95,390,050 -3,161,331 -2,555,901
Net Income -62,509,764 -94,235,825 -3,136,016 -2,526,921
Gross Margin 38.4% 38.4% 65.3% 65.3%
Operating Margin -4,650.5% -4,185.5% -16.4% -13.7%
Profit Margin -4,594.3% -4,364.5% -16.3% -13.6%
Rev Growth -40.3% -40.3% -5.9% +5.1%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 17.60M 17.60M 23.44M 21.95M
Total Equity 19.36M 19.36M 30.82M 33.89M
D/E Ratio 0.91 0.91 0.76 0.65
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -60,706,323 -96,601,351 -4,591,050 -4,236,243
Free Cash Flow -2,958,449 -2,128,422